Navigation Links
Viral Therapy Slows Pediatric Tumors in Mice
Date:2/15/2008

at aid the development and progression of cancer, called matrix of metalloproteinases (MMP).

MMPs help break down molecules that are important for the structural support and normal development of cells, organs and maintenance of tissues. However, when MMP activity becomes unbalanced, the enzyme plays a well-documented role in the formation of invasive and metastatic cancers, including pediatric neuroblastoma.

More information

The National Cancer Institute has more about childhood cancers.



-- Kevin McKeever



SOURCE: Cincinnati Children's Hospital Medical Center, news release, Feb. 15, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients
2. IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide
3. Antiretroviral Drugs May Prevent Vaginal Transmission of HIV
4. MIGENIX Reports Preliminary Celgosivir Viral Kinetics Study
5. Antivirals reduce deaths from flu in hospitalized patients
6. American Medical Association Clears Path for Adenoviral Conjunctivitis - Pink Eye - Detector
7. Is it pancreatitis in acute abdominal pain in acute viral hepatitis?
8. Mayo Clinic Proceedings article explores possible link between obesity and viral infections
9. Antiviral Wont Improve Bells Palsy Outcome
10. Key Viral Change Could Help Bird Flu Spread
11. DNA damage response confers a barrier for viral tumorigenesis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Viral Therapy Slows Pediatric Tumors in Mice
Viral Therapy Slows Pediatric Tumors in Mice
(Date:12/14/2009)... revolutionary new liposuction and fat transfer treatments can help people ... one minimally invasive treatment. , ... ... NaturalFill™ can remove excess fat from the abdomen and inject ... down, reduce facial wrinkling and enhance lips all in one ...
(Date:12/14/2009)... Corporation (NYSE: HAE ) announced today ... to stop Fenwal Inc.,s continued patent infringement resulting ... using a modified separation chamber. Fenwal allegedly ... and the injunction entered by the Court prohibiting ... 1, 2010. According to statements made by ...
(Date:12/14/2009)... , , MONDAY, Dec. 14 (HealthDay News) -- U.S. researchers ... gene linked to heart failure. , The team at ... the DNA of a large group of white patients ... genes that could be connected with heart failure. Further ... healthy whites led the researchers to identify 12 variants ...
(Date:12/14/2009)... Dec. 14 Skilled nursing facilities (SNFs) in ... in order to deal with a 92 percent increase ... from $6.25 to $12.01 per bed per day, scheduled ... average facility will pay an additional $17,520 to the ... total tax of $438,365 yearly. ,, Nearly 96 percent ...
(Date:12/14/2009)... DENVER, Dec. 14 On December 9, 2009, ... the federal government,s position that private insurance companies are ... Frost) ,, Although other federal courts have held that ... federal jurisdiction under Title 18 Section 1347, US ... company itself has been held to be a "plan," ...
Breaking Medicine News(10 mins):Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 2Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 3Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3Health News:Insurance Now Subject to Federal Jurisdiction 2
... with Invisicare Available For International Licensing, ... (OTC,Bulletin Board: SKVI)( http://www.skinvisible.com, , http://www.invisicare.com ), ... system that enhances topical skincare products, announces,the ... sunscreen combining the,active ingredient avobenzone (Parsol(R) 1789) ...
... that regular,monitoring of medications by physicians is an ... Thanks to recent advances in the SMART,Registry, physicians ... their,patients that they never received before., Highmark ... regularly,their chronically ill patients fill their prescriptions., ...
... has identified processes that are heavily implicated in human multiple ... developing quick tests and readouts that could help in the ... cells that produce antibodies, form a key part of our ... right number of B cells, not too many and not ...
... quadruple in certain populations if people with HIV follow ... Swiss Federal Commission for HIV/AIDS, University of New South ... UNSW,s National Centre in HIV Epidemiology and Clinical Research ... from the Swiss Federal Commission for HIV/AIDS that stated ...
... quickly once smoking spouse quits , , TUESDAY, July 29 (HealthDay ... significantly higher risk for experiencing a stroke, a new study ... and women who still smoke carry an even greater risk ... appear to bear any higher risk for stroke than those ...
... Remain the Clinical Gold Standard Drug Through 2016, According ... to a New Report from Decision ... of the,world,s leading research and advisory firms focusing on pharmaceutical ... and has a lower discontinuation rate than that of Abbott,s,Niaspan ...
Other Medicine News:Health News:Skinvisible Offers 8 Hour Photostablity for Parsol 1789 2Health News:Skinvisible Offers 8 Hour Photostablity for Parsol 1789 3Health News:Highmark's SMART(TM) Registry Reports Aid the Chronically Ill 2Health News:Highmark's SMART(TM) Registry Reports Aid the Chronically Ill 3Health News:How molecules out of balance lead to human multiple myeloma and other cancers 2Health News:A dangerous precedent in HIV 2Health News:Secondhand Smoke Raises Stroke Risk for Spouses 2Health News:Secondhand Smoke Raises Stroke Risk for Spouses 3Health News:A High-Density Lipoprotein Raising Drug That Has a Lower Discontinuation Rate Than That of Extended Release Niaspan Would Earn a 20 Percent Patient Share in the Dyslipidemia Drug Market 2
(Date:12/14/2009)... -- BioTrends Research Group, Inc. released ChartTrends®: ... offering comprehensive insight into the management of RA ... comparison of self-reported treatment approaches (as reported by ... over 1,000 RA patients who are currently being ... for the audit, patients had to currently be ...
(Date:12/14/2009)... In response to an FDA ... which the Agency recommended that healthcare facilities discontinue ... processing system, hospitals throughout the U.S. are faced ... that product. According to the FDA, STERIS made ... may affect the safety or the effectiveness of ...
(Date:12/14/2009)... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... Application (NDA) for Staccato® loxapine (AZ-004) to the US ... inhalation product candidate being developed for the rapid treatment ... The IND for Staccato loxapine was ... has delivered a predictable and consistent safety and efficacy ...
Breaking Medicine Technology:New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 2New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 3ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Simple Test Might Detect Silent Heart Disease 58798 1Simple Test Might Detect Silent Heart Disease 58798 2Mayo Clinic Executive Brent Phillips to Join Aurora Medical Group as Chief Operating Officer 58794 1Mayo Clinic Executive Brent Phillips to Join Aurora Medical Group as Chief Operating Officer 58794 2CardioGenics Holdings Inc Engages Gilford Securities As Investment Banker 14339 1CardioGenics Holdings Inc Engages Gilford Securities As Investment Banker 14339 2
... injuries may be the culpritROSEMONT, Ill., May 1 ... sudden twist or blow to the ankle joint., , ... an ankle sprain will experience chronic ankle pain, even after being treated for ... A review article published in the May 2009 issue of the ...
... provider of clinical services and trial management technologies for ... along with its client Genentech, Inc as the winner ... Clinical Trial Portal solution. Winners were selected from ... panel of 14 expert judges. The ePharmaSolutions Clinical ...
Other Medicine Technology:Chronic Ankle Pain May Be More Than Just a Sprain 2Chronic Ankle Pain May Be More Than Just a Sprain 3ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award 2
... frames. They are made of optical quality acrylic and ... are two sets available providing a full range of ... a patient can wear the prism with the trial ... to adapt to the use of the prism. Patient ...
Developed for reconstructive plastic surgery with E-Type coupling. Order blades by size from 12 mm, 25 mm, 50 mm or 75 mm depending on your specific case requirements. Blades come in packs of 10....
Corneal rust ring remover battery powered, extra burr 1.0 mm....
BD Visitec IOL Manipulator (Lester), 0.25 mm diameter tip angled 45 in, 10 mm from end (3/bx, 1 bx/ca), sterile. For positioning intraocular lenses. Sure grip handles hand ridge indicating position o...
Medicine Products: